Lexicon Pharma (LXRX) Announces COO Departuree

On September 13, 2024, Lexicon Pharma (NASDAQ: LXRX) and Jeffrey L. Wade determined that his employment as our president and chief operating officer (in which capacity, Mr. Wade has functioned as our principal financial officer) would terminate as of September 30, 2024.

You May Also Be Interested In

• Uber sells part of its Aurora stake in block trade - Bloomberg
• New to The Street Expands Bloomberg Television Sponsored Programming Across Asia-Pacific, Adding Nearly 69 Million Homes
• Join Bimergen Energy's Live Investor Webinar: Building a Leading Battery Energy Storage Platform to Power the Future Grid